why choose us

First received: January 29, 2023

Clinical Trial: Focal Laser Single Intravitreal Ranibizumab Retinal Artery Macroaneurysm.

Study Status: Completed

Recruit Status: Completed

Condition: Retinal Artery Macroaneurysm

Study Type: Observational


Official Title: Validity of Focal Laser Photocoagulation Followed by a Single Intravitreal Ranibizumab Injection for Retinal Artery Macroaneurysm.

Brief Summary: Treatment options for Retinal artery Macroaneurysm (RAM) include focal laser photocoagulation, intravitreal anti-Vascular Endothelial Growth Factor (anti-VEGF) injection, combined anti VEGF - laser therapy, YAG hyaloidotomy and pars plana vitrectomy. Focal laser photocoagulation is applied directly to the macroaneurysm (direct lesional), its surrounding area (indirect perilesional) or a combination of both. [3-5] Anti-VEGF agents including bevacizumab and ranibizumab reduce leakage from the macroaneurysm. [3-15]…

Read more